With as many as 188 cases of Mucormycosis (Black Fungus) reported in the state so far, Chief Minister Captain Amarinder Singh on Thursday ordered a ramp-up of stocks of alternate drugs to treat the disease in view of the shortage of Amphotericin.
"With only Liposomal Amphotericin B injections in the stock, and just 880 more Liposomal expected to be received today (Thursday), the CM stressed the need to strengthen alternate drug stocks as recommended by the Expert Group constituted by his government to deal with the crisis," read an official release.
Emphasising the need to ensure that every patient has a chance to recover from Black Fungus, a disease reportedly caused by the overuse of steroids in COVID treatment, especially those suffering from diabetes, the Chief Minister said that along with efforts to get more of the Amphotericin drug, the state government has already made available the alternate drugs - Itraconazole (4,000 tablets) and Posaconazole (5,00 tablets), as suggested by the Expert Group.
He also noted that the 6-member Expert Group has begun its task of advising hospitals on the treatment protocols and the use of various drugs being supplied to them.
Giving details of the confirmed cases of Black Fungus reported till date in the government hospitals, Medical Education Secretary DK Tiwari disclosed that the maximum of 16 cases had come to light at Government Medical College (GMC), Patiala, followed by GMC Amritsar (10), GMC Faridkot (8) and GMC Mohali (2).
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)